Sensus Healthcare prices IPO

Sensus Healthcare prices IPO
07/06/2016 13:08

Sensus Healthcare, Inc., a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, announced the pricing of its initial public offering of 2 million units at a public offering price of USD 5.50 per unit, before underwriting discounts and commission. Each unit consists of one share of common stock, USD 0.01 par value per share, and a three-year warrant to purchase one share of common stock at an initial exercise price of USD 6.75 per share. All of the units are being offered by Sensus. In addition, Sensus has granted the underwriters a 45-day option to purchase up to 300,000 additional units at the initial public offering price, less underwriting discounts and commissions. The units will commence trading on The NASDAQ Capital Market on Friday, June 3, 2016, under the ticker symbol "SRTSU." The offering is expected to close on or about June 8, 2016, subject to satisfaction of customary closing condition